103546-10-7 Usage
Uses
Used in Pharmaceutical Synthesis:
3-(2-Nitrophenoxy)propylamine is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the formation of complex molecular structures that can exhibit therapeutic effects.
Used in Organic Chemistry:
In the realm of organic chemistry, 3-(2-Nitrophenoxy)propylamine is used as a versatile intermediate, facilitating the creation of a range of organic compounds due to its reactive functional groups.
Used in Research Laboratories:
3-(2-Nitrophenoxy)propylamine is utilized in research settings to explore its unique chemical properties and potential applications in chemical reactions and compound development.
Used in Drug Production:
As a starting material in the production of various drugs, 3-(2-Nitrophenoxy)propylamine plays a significant role in the pharmaceutical industry, contributing to the development of new medications and therapies.
It is important to handle 3-(2-Nitrophenoxy)propylamine with care due to its potential health hazards if not used properly, emphasizing the need for safety measures in its application across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 103546-10-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,5,4 and 6 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 103546-10:
(8*1)+(7*0)+(6*3)+(5*5)+(4*4)+(3*6)+(2*1)+(1*0)=87
87 % 10 = 7
So 103546-10-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2O3/c10-6-3-7-14-9-5-2-1-4-8(9)11(12)13/h1-2,4-5H,3,6-7,10H2
103546-10-7Relevant articles and documents
Selective small molecules blocking HIV-1 tat and coactivator PCAF association
Zeng, Lei,Li, Jiaming,Muller, Michaela,Yan, Sherry,Mujtaba, Shiraz,Pan, Chongfeng,Wang, Zhiyong,Zhou, Ming-Ming
, p. 2376 - 2377 (2007/10/03)
Development of drug resistance from mutations in the targeted viral proteins leads to continuation of viral production by chronically infected cells, contributing to HIV-mediated immune dysfunction. Targeting a host cell protein essential for viral reproduction, rather than a viral protein, may minimize the viral drug resistance problem as observed with HIV protease inhibitors. We report here the development of a novel class of N1-aryl-propane-1,3-diamine compounds using a structure-based approach that selectively inhibit the activity of the bromodomain of the human transcriptional co-activator PCAF, of which association with the HIV trans-activator Tat is essential for transcription and replication of the integrated HIV provirus. Copyright